Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS opens coverage analysis on oxygen for cluster headaches

This article was originally published in The Gray Sheet

Executive Summary

At the request of the American Headache Society and the American Academy of Neurology, CMS opened a national coverage analysis April 9 on home use of oxygen to treat cluster headaches. Current durable medical equipment policy on home oxygen does not address its use to treat cluster headaches, which CMS says may impact as many as 36,000 Medicare beneficiaries. According to the agency, cluster headaches may occur over many weeks, and are characterized by severe stabbing pain behind the eye, often accompanied by redness and tearing of the eye, as well as nasal congestion. Comments are due May 9

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel